A Trial of Oral Nutritional Supplements on Nutritional Status and Clinical Outcomes
Launched by SINGAPORE GENERAL HOSPITAL · Aug 27, 2010
Trial Information
Current as of May 27, 2025
Withdrawn
Keywords
ClinConnect Summary
Nutritional supplements have been shown to improve energy, protein, micronutrients intake, maintain or improve nutritional status in hospitalized malnourished elderly patients. However, its use in the elderly post-hospitalization is unknown, particularly in the local setting. This randomized controlled trial aims to investigate if provision of short term nutritional supplements to elderly malnourished patients after discharge from hospital improves nutritional status parameters. In addition, the impact of nutritional supplements on functional status, clinical outcome in terms of hospital re...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • over the age of 65 years old and to be discharged from Geriatric ward
- • malnourished screened by Malnutrition Universal Screening Tool
- Exclusion Criteria:
- • are uncommunicative
- • have a history of diabetes, chronic renal failure, liver disease
- • are from long term residential homes like nursing homes
- • incapable of taking study supplements to provide a minimum of 600 kcal/day as part of food intake
- • intolerant to any of the ingredients in the study nutritional supplements
- • require parenteral nutrition or enteral feeds as sole source of nutrition, e.g. patients who discharge home with tube feeding
About Singapore General Hospital
Singapore General Hospital (SGH) is a leading academic medical center in Singapore, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, SGH plays a pivotal role in conducting cutting-edge studies that aim to improve patient outcomes and enhance medical knowledge across various specialties. With a strong focus on collaboration and multidisciplinary approaches, SGH leverages its extensive resources and expertise to facilitate rigorous clinical trials, ensuring the highest standards of safety and efficacy in the development of new treatments and therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Lee Boo Tan, BSc, MSc
Principal Investigator
Dietetics & Nutrition Services, Singapore General Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials